The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Eotaxin (CCL11) Induces In Vivo Angiogenic Responses by Human CCR3+ Endothelial Cells
Abstract
Chemokines are attractants and regulators of cell activation. Several CXC family chemokine members induce angiogenesis and promote tumor growth. In contrast, the only CC chemokine, reported to play a direct role in angiogenesis is monocyte-chemotactic protein-1. Here we report that another CC chemokine, eotaxin (also known as CCL11), also induced chemotaxis of human microvascular endothelial cells. CCL11-induced chemotactic responses were comparable with those induced by monocyte-chemotactic protein-1 (CCL2), but lower than those induced by stroma-derived factor-1α (CXCL12) and IL-8 (CXCL8). The chemotactic activity was consistent with the expression of CCR3, the receptor for CCL11, on human microvascular endothelial cells and was inhibited by mAbs to either human CCL11 or human CCR3. CCL11 also induced the formation of blood vessels in vivo as assessed by the chick chorioallantoic membrane and Matrigel plug assays. The angiogenic response induced by CCL11 was about one-half of that induced by basic fibroblast factor, and it was accompanied by an inflammatory infiltrate, which consisted predominantly of eosinophils. Because the rat aortic sprouting assay, which is not infiltrated by eosinophils, yielded a positive response to CCL11, this angiogenic response appears to be direct and is not mediated by eosinophil products. This suggests that CCL11 may contribute to angiogenesis in conditions characterized by increased CCL11 production and eosinophil infiltration such as Hodgkin’s lymphoma, nasal polyposis, endometriosis, and allergic diathesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
Tachibana, K., Hirota, S., Iizasa, H., Yoshida, H., Kawabata, K., Kataoka, Y., Kitamura, Y., Matsushima, K., Yoshida, N., Nishikawa, S.-I., et al. (1998) · Nature · doi:10.1038/31261 · Cited by 1,525
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27348 · Cited by 1,222
Selective Expression of the Eotaxin Receptor CCR3 by Human T Helper 2 Cells
Sallusto, F., Mackay, C. R., & Lanzavecchia, A. (1997) · Science · doi:10.1126/science.277.5334.2005 · Cited by 1,050
Salcedo, R., Ponce, M. L., Young, H. A., Wasserman, K., Ward, J. M., Kleinman, H. K., Oppenheim, J. J., & Murphy, W. J. (2000) · Blood · doi:10.1182/blood.v96.1.34 · Cited by 859
Self-citationPonath, P. D., Qin, S., Ringler, D. J., Clark-Lewis, I., Wang, J., Kassam, N., Smith, H., Shi, X., Gonzalo, J. A., Newman, W., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118456 · Cited by 697
Salcedo, R., Wasserman, K., Young, H. A., Grimm, M. C., Howard, O. M. Z., Anver, M. R., Kleinman, H. K., Murphy, W. J., & Oppenheim, J. J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65365-5 · Cited by 540
Self-citationTargeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia
Rothenberg, M. E., MacLean, J. A., Pearlman, E., Luster, A. D., & Leder, P. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.785 · Cited by 524
Angiogenic and HIV-Inhibitory Functions of KSHV-Encoded Chemokines
Boshoff, C., Endo, Y., Collins, P. D., Takeuchi, Y., Reeves, J. D., Schweickart, V. L., Siani, M. A., Sasaki, T., Williams, T. J., Gray, P. W., et al. (1997) · Science · doi:10.1126/science.278.5336.290 · Cited by 469
Engelhardt, E., Toksoy, A., Goebeler, M., Debus, S., Bröcker, E.-B., & Gillitzer, R. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65699-4 · Cited by 435
Chemokine Receptors in Human Endothelial Cells
Gupta, S. K., Lysko, P. G., Pillarisetti, K., Ohlstein, E., & Stadel, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.4282 · Cited by 407
Coughlin, C. M., Salhany, K. E., Gee, M. S., LaTemple, D. C., Kotenko, S., Ma, X., Gri, G., Wysocka, M., Kim, J. E., Liu, L., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80585-3 · Cited by 324
Eotaxin is required for the baseline level of tissue eosinophils
Matthews, A. N., Friend, D. S., Zimmermann, N., Sarafi, M. N., Luster, A. D., Pearlman, E., Wert, S. E., & Rothenberg, M. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6273 · Cited by 287
Salcedo, R., Resau, J. H., Halverson, D., Hudson, E. A., Dambach, M., Powell, D., Wasserman, K., & Oppenheim, J. J. (2000) · The FASEB Journal · doi:10.1096/fj.99-0963com · Cited by 245
Self-citationEotaxin and eosinophil recruitment: implications for human disease
Rankin, S. M., Conroy, D. M., & Williams, T. J. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01635-4 · Cited by 243
THE ROLE OF CXC CHEMOKINES AS REGULATORS OF ANGIOGENESIS
Strieter, R. M., Polverini, P. J., Arenberg, D. A., & Kunkel, S. L. (1995) · Shock · doi:10.1097/00024382-199509000-00001 · Cited by 236
Eosinophil infiltration of human colonic carcinomas as a prognostic indicator.
Pretlow, T. P., Keith, E. F., Cryar, A., et al. (1983) · PubMed · Cited by 195
Prognostic influence of tumor‐associated eosinophilic infiltrate in colorectal carcinoma
Fernández‐Aceñero, M. J., Galindo‐Gallego, M., Sanz, J., & Aljama, A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000401)88:7<1544::aid-cncr7>3.3.co;2-j · Cited by 175
Feil, C., & Augustin, H. G. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8499 · Cited by 172
The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer
Arenberg, D. A., Polverini, P. J., Kunkel, S. L., Shanafelt, A., Hesselgesser, J., Horuk, R., & Strieter, R. M. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.5.554 · Cited by 158
Samoszuk, M. K. (1997) · PubMed · Cited by 156
Luster, A. D., & Rothenberg, M. E. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.5.620 · Cited by 153
Teruya‐Feldstein, J., Jaffe, E. S., Burd, P. R., Kingma, D. W., Setsuda, J., & Tosato, G. (1999) · Blood · doi:10.1182/blood.v93.8.2463.408k02_2463_2470 · Cited by 147
CXC and CC Chemokine Receptors on Coronary and Brain Endothelia
Berger, O., Gan, X.-H., Gujuluva, C. N., Burns, A. R., Sulur, G., Stins, M. F., Way, D., Witte, M. H., Weinand, M. E., SAID, J. W., et al. (1999) · Molecular Medicine · doi:10.1007/bf03401992 · Cited by 131
Pericle, F., Giovarelli, M., Colombo, M. P., Ferrari, G., Musiani, P., Modesti, A., Cavallo, F., Pierro, F. D., Novelli, F., & Forni, G. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.12.5659 · Cited by 131
Elovic, A., Wong, D. T., Weller, P. F., Matossian, K., & Galli, S. J. (1994) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(94)90379-4 · Cited by 128
Chemokine receptors in the human brain and their relationship to HIV infection
Lavi, E., Kolson, D. L., Ulrich, A. M., Fu, L., & González‐Scarano, F. (1998) · Journal of NeuroVirology · doi:10.3109/13550289809114531 · Cited by 127
Chymase as a Proangiogenic Factor
Muramatsu, M., Katada, J., Hayashi, I., & Majima, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5545 · Cited by 109
Eotaxin Is a Potent Chemotaxin for Human Basophils
Yamada, H., Hirai, K., Miyamasu, M., Iikura, M., Misaki, Y., Shoji, S., Takaishi, T., Kasahara, T., Morita, Y., & Ito, K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6100 · Cited by 102
Chung, K. F., Patel, H. J., Fadlon, E., Rousell, J., Haddad, E., Jose, P. J., Mitchell, J. A., & Belvisi, M. G. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702660 · Cited by 99
Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10
Cervenak, L., Morbidelli, L., Donati, D., Donnini, S., Kambayashi, T., Wilson, J. L., Axelson, H., Castaños‐Vélez, E., Ljunggren, H., Malefyt, R. D. W., et al. (2000) · Blood · doi:10.1182/blood.v96.7.2568 · Cited by 97
I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo
Bernardini, G., Spinetti, G., Ribatti, D., Camarda, G., Morbidelli, L., Ziche, M., Santoni, A., Capogrossi, M. C., & Napolitano, M. (2000) · Blood · doi:10.1182/blood.v96.13.4039 · Cited by 95
Antigen-Induced Eosinophilic Lung Inflammation Develops in Mice Deficient in Chemokine Eotaxin
Yang, Y., Loy, J. K., Ryseck, R.-P., Carrasco, D. R., & Bravo, R. (1998) · Blood · doi:10.1182/blood.v92.10.3912 · Cited by 93
Gene Transfer of IFN-γ into Established Brain Tumors Represses Growth by Antiangiogenesis
Fathallah‐Shaykh, H. M., Zhao, L.-J., Kafrouni, A. I., Smith, G. M., & Forman, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.217 · Cited by 88
Terada, Hamano, Nomura, Numata, Hirai, Nakajima, Yamada, Yoshie, O., Ikeda‐Ito, & Konno (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00750.x · Cited by 77
Chymase mediates mast cell-induced angiogenesis in hamster sponge granulomas
Muramatsu, M., Katada, J., Hattori, M., Hayashi, I., & Majima, M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00350-2 · Cited by 64
Degranulating Eosinophils in Human Endometriosis
Blumenthal, R. D., Samoszuk, M. K., Taylor, A. P., Brown, G., Alisauskas, R. M., & Goldenberg, D. M. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65030-4 · Cited by 64
Setsuda, J., Teruya‐Feldstein, J., Harris, N. L., Ferry, J. A., Sorbara, L. R., Gupta, G. D., Jaffe, E. S., & Tosato, G. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65119-x · Cited by 63
Th1-derived cytokine IFN-gamma is a potent inhibitor of eotaxin synthesis in vitro
Miyamasu, M., Yamaguchi, M., Nakajima, T., Misaki, Y., Morita, Y., Matsushima, K., Yamamoto, K., & Hirai, K. (1999) · International Immunology · doi:10.1093/intimm/11.6.1001 · Cited by 49
Eotaxin and Capping Protein in Experimental Vasculopathy
Chen, J., Akyürek, L. M., Fellström, B., Häyry, P., & Paul, L. C. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65548-4 · Cited by 17
Cited by
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642
Roussos, E. T., Condeelis, J. S., & Patsialou, A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3078 · Cited by 896
Bachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
Macrophage inflammatory protein-1
Menten, P., Wuyts, A., & Van Damme, J. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00045-x · Cited by 706
Metadata
- Authors
- Salcedo, R., Young, H. A., Ponce, M. L., Ward, J. M., Kleinman, H. K., Murphy, W. J., & Oppenheim, J. J.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-06
- Volume
- 166
- Issue
- 12
- Pages
- 7571-7578
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1953191479
- Cited by
- 257
- References
- 40
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.